Involvement of P38MAPK in human corneal endothelial cell migration induced by TGF-β2

Experimental Eye Research

Volumn 108, Issue , 2013, Pages 23-32

  Joko, Takeshi ^a   Shiraishi, Atsushi ^a   Akune, Yoko ^a   Tokumaru, Sho ^a   Kobayashi, Takeshi ^a   Miyata, Kazunori ^b   Ohashi, Yuichi ^a  

^a EHIME UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b Miyata Eye Hospital   (Japan)

Author keywords

Cell migration; Corneal endothelial wound healing; FGF 2; P38MAPK; TGF 2

Indexed keywords

4 [4 (4 FLUOROPHENYL) 5 (2 METHOXY 4 PYRIMIDINYL) 1 IMIDAZOLYL]CYCLOHEXANOL; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE P38; STRESS ACTIVATED PROTEIN KINASE; SYNAPTOPHYSIN; TRANSFORMING GROWTH FACTOR BETA2;

ARTICLE; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; CORNEA ENDOTHELIUM; ENDOTHELIUM CELL; ENZYME PHOSPHORYLATION; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; IN VITRO STUDY; PHARMACOLOGICAL BLOCKING; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; WOUND HEALING;

CELL MOVEMENT; CELL PROLIFERATION; CELLS, CULTURED; ENDOTHELIAL CELLS; ENDOTHELIUM, CORNEAL; ENZYME ACTIVATION; FIBROBLAST GROWTH FACTOR 2; HUMANS; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHORYLATION; PROTEIN KINASE INHIBITORS; PROTEIN-SERINE-THREONINE KINASES; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA; RECOMBINANT PROTEINS; RNA, MESSENGER; SIGNAL TRANSDUCTION; TIME FACTORS; TRANSFORMING GROWTH FACTOR BETA2; WOUND HEALING;

EID: 84872437118     PISSN: 00144835     EISSN: 10960007     Source Type: Journal    
DOI: 10.1016/j.exer.2012.11.018     Document Type: Article

References (41)

1. Boyden S. The chemotactic effect of mixtures of antibody and antigen on polymorphonuclear leucocytes. J. Exp. Med. 1962, 115:453-466.
2. Byfield S.D., Roberts A.B. Lateral signaling enhances TGF-beta response complexity. Trends Cell Biol. 2004, 14:107-111.
3. Chen K.H., Harris D.L., Joyce N.C. TGF-beta2 in aqueous humor suppresses S-phase entry in cultured corneal endothelial cells. Invest. Ophthalmol. Vis. Sci. 1999, 40:2513-2519.
4. Chen W.L., Lin C.T., Li J.W., Hu F.R., Chen C.C. ERK1/2 activation regulates the wound healing process of rabbit corneal endothelial cells. Curr. Eye Res. 2009, 34:103-111.
5. Cousins S.W., McCabe M.M., Danielpour D., Streilein J.W. Identification of transforming growth factor-beta as an immunosuppressive factor in aqueous humor. Invest. Ophthalmol. Vis. Sci. 1991, 32:2201-2211.
6. Cuadrado A., Nebreda A.R. Mechanisms and functions of p38 MAPK signalling. Biochem. J. 2010, 429:403-417.
7. Furuyama A., Iwata M., Hayashi T., Mochitate K. Transforming growth factor-beta1 regulates basement membrane formation by alveolar epithelial cells in vitro. Eur. J. Cell. Biol. 1999, 78:867-875.
8. Gailit J., Welch M.P., Clark R.A. TGF-beta 1 stimulates expression of keratinocyte integrins during re-epithelialization of cutaneous wounds. J. Invest. Dermatol. 1994, 103:221-227.
9. Grant M.B., Khaw P.T., Schultz G.S., Adams J.L., Shimizu R.W. Effects of epidermal growth factor, fibroblast growth factor, and transforming growth factor-beta on corneal cell chemotaxis. Invest. Ophthalmol. Vis. Sci. 1992, 33:3292-3301.
10. Harris D.L., Joyce N.C. Transforming growth factor-beta suppresses proliferation of rabbit corneal endothelial cells in vitro. J. Interferon. Cytokine Res. 1999, 19:327-334.
11. Hoppenreijs V.P., Pels E., Vrensen G.F., Treffers W.F. Basic fibroblast growth factor stimulates corneal endothelial cell growth and endothelial wound healing of human corneas. Invest. Ophthalmol. Vis. Sci. 1994, 35:931-944.
12. Huang C., Jacobson K., Schaller M.D. MAP kinases and cell migration. J. Cell Sci. 2004, 117:4619-4628.
13. Itoh S., ten Dijke P. Negative regulation of TGF-beta receptor/Smad signal transduction. Curr. Opin. Cell Biol. 2007, 19:176-184.
14. Jampel H.D., Roche N., Stark W.J., Roberts A.B. Transforming growth factor-beta in human aqueous humor. Curr. Eye Res. 1990, 9:963-969.
15. Joko T., Nanba D., Shiba F., Miyata K., Shiraishi A., Ohashi Y., Higashiyama S. Effects of promyelocytic leukemia zinc finger protein on the proliferation of cultured human corneal endothelial cells. Mol. Vis. 2007, 13:649-658.
16. Joyce N.C. Proliferative capacity of the corneal endothelium. Prog. Retin. Eye Res. 2003, 22:359-389.
17. Joyce N.C., Zieske J.D. Transforming growth factor-beta receptor expression in human cornea. Invest. Ophthalmol. Vis. Sci. 1997, 38:1922-1928.
18. Kim T.Y., Kim W.I., Smith R.E., Kay E.D. Role of p27(Kip1) in cAMP- and TGF-beta2-mediated antiproliferation in rabbit corneal endothelial cells. Invest. Ophthalmol. Vis. Sci. 2001, 42:3142-3149.
19. Kim T.Y., Kim W.I., Smith R.E., Kay E.P. Differential activity of TGF-beta2 on the expression of p27Kip1 and Cdk4 in actively cycling and contact inhibited rabbit corneal endothelial cells. Mol. Vis. 2001, 7:261-270.
20. Landshman N., Ben-Hanan I., Assia E., Ben-Chaim O., Belkin M. Relationship between morphology and functional ability of regenerated corneal endothelium. Invest. Ophthalmol. Vis. Sci. 1988, 29:1100-1109.
21. Lee J.G., Song J.S., Smith R.E., Kay E.P. Human corneal endothelial cells employ phosphorylation of p27(Kip1) at both Ser10 and Thr187 sites for FGF-2-mediated cell proliferation via PI 3-kinase. Invest. Ophthalmol. Vis. Sci. 2011, 52:8216-8223.
22. Ling T.L., Vannas A., Holden B.A. Long-term changes in corneal endothelial morphology following wounding in the cat. Invest. Ophthalmol. Vis. Sci. 1988, 29:1407-1412.
23. Massague J., Gomis R.R. The logic of TGFbeta signaling. FEBS Lett. 2006, 580:2811-2820.
24. Miyata K., Drake J., Osakabe Y., Hosokawa Y., Hwang D., Soya K., Oshika T., Amano S. Effect of donor age on morphologic variation of cultured human corneal endothelial cells. Cornea 2001, 20:59-63.
25. Murphy C., Alvarado J., Juster R., Maglio M. Prenatal and postnatal cellularity of the human corneal endothelium. A quantitative histologic study. Invest. Ophthalmol. Vis. Sci. 1984, 25:312-322.
26. Picht G., Welge-Luessen U., Grehn F., Lutjen-Drecoll E. Transforming growth factor beta 2 levels in the aqueous humor in different types of glaucoma and the relation to filtering bleb development. Graefes Arch. Clin. Exp. Ophthalmol. 2001, 239:199-207.
27. Rieck P., Oliver L., Engelmann K., Fuhrmann G., Hartmann C., Courtois Y. The role of exogenous/endogenous basic fibroblast growth factor (FGF2) and transforming growth factor beta (TGF beta-1) on human corneal endothelial cells proliferation in vitro. Exp. Cell Res. 1995, 220:36-46.
28. Rieck P.W., Cholidis S., Hartmann C. Intracellular signaling pathway of FGF-2-modulated corneal endothelial cell migration during wound healing in vitro. Exp. Eye Res. 2001, 73:639-650.
29. Saika S. TGF-beta signal transduction in corneal wound healing as a therapeutic target. Cornea 2004, 23:S25-S30.
30. Saika S., Okada Y., Miyamoto T., Yamanaka O., Ohnishi Y., Ooshima A., Liu C.Y., Weng D., Kao W.W. Role of p38 MAP kinase in regulation of cell migration and proliferation in healing corneal epithelium. Invest. Ophthalmol. Vis. Sci. 2004, 45:100-109.
31. Sharma G.D., He J., Bazan H.E. p38 and ERK1/2 coordinate cellular migration and proliferation in epithelial wound healing: evidence of cross-talk activation between MAP kinase cascades. J. Biol. Chem. 2003, 278:21989-21997.
32. Solly K., Wang X., Xu X., Strulovici B., Zheng W. Application of real-time cell electronic sensing (RT-CES) technology to cell-based assays. Assay Drug Dev. Technol. 2004, 2:363-372.
33. Terai K., Call M.K., Liu H., Saika S., Liu C.Y., Hayashi Y., Chikama T., Zhang J., Terai N., Kao C.W., et al. Crosstalk between TGF-beta and MAPK signaling during corneal wound healing. Invest. Ophthalmol. Vis. Sci. 2011, 52:8208-8215.
34. Thalmann-Goetsch A., Engelmann K., Bednarz J. Comparative study on the effects of different growth factors on migration of bovine corneal endothelial cells during wound healing. Acta Ophthalmol. Scand. 1997, 75:490-495.
35. Treffers W.F. Human corneal endothelial wound repair. In vitro and in vivo. Ophthalmology 1982, 89:605-613.
36. Tripathi R.C., Li J., Chan W.F., Tripathi B.J. Aqueous humor in glaucomatous eyes contains an increased level of TGF-beta 2. Exp. Eye Res. 1994, 59:723-727.
37. van Setten G.B., Fagerholm P., Philipson B., Schultz G. Growth factors and their receptors in the anterior chamber. Absence of epidermal growth factor and transforming growth factor alpha in human aqueous humor. Ophthalmic Res. 1996, 28:361-364.
38. Wang Z., Yang H., Tachado S.D., Capo-Aponte J.E., Bildin V.N., Koziel H., Reinach P.S. Phosphatase-mediated crosstalk control of ERK and p38 MAPK signaling in corneal epithelial cells. Invest. Ophthalmol. Vis. Sci. 2006, 47:5267-5275.
39. Whikehart D.R., Parikh C.H., Vaughn A.V., Mishler K., Edelhauser H.F. Evidence suggesting the existence of stem cells for the human corneal endothelium. Mol. Vis. 2005, 11:816-824.
40. Wilson S.E., Lloyd S.A. Epidermal growth factor and its receptor, basic fibroblast growth factor, transforming growth factor beta-1, and interleukin-1 alpha messenger RNA production in human corneal endothelial cells. Invest. Ophthalmol. Vis. Sci. 1991, 32:2747-2756.
41. Xing J.Z., Zhu L., Jackson J.A., Gabos S., Sun X.J., Wang X.B., Xu X. Dynamic monitoring of cytotoxicity on microelectronic sensors. Chem. Res. Toxicol. 2005, 18:154-161.